Vernakalant

A potent inhibitor of VEGF receptors, inhibiting VEGFR1, 2, and 3 with IC₅₀ values of 130, 23, and 18 nM, respectively orally bioavailable in vivo, blocking VEGF-induced angiogenesis and preventing the growth of primary tumors and

General description Lin28 is a developmentally regulated RNA binding protein (RBP). It&#8217:s down regulation is mediated in part by Lin4 and miR-125b, the mammalian micro-RNA homolog of Lin4.

Lin28 is a developmentally regulated RNA binding protein (RBP). It&#8217s down regulation is mediated in part by Lin4 and miR-125b, the mammalian micro-RNA homolog of Lin4.

General description VEGF (Vascular endothelial growth factor, VEGFA, VEGF-A), a dimeric ligand, is among the most potent angiogenic mitogens. VEGF is secreted by tumor cells and other cells exposed to hypoxia.

VEGF (Vascular endothelial growth factor, VEGFA, VEGF-A), a dimeric ligand, is among the most potent angiogenic mitogens. VEGF is secreted by tumor cells and other cells exposed to hypoxia.

Anti-VEGFA vascular endothelial growth factor A, 100ul UN 16

Anti-VEGFD vascular endothelial growth factor D, 100ul UN 16

Anti-VEGFD vascular endothelial growth factor D, 25ul UN 168

Book 4, Lymphedema and Chronic Swelling (Products cannot be sold on Amazon.com or any other 3rd party platform) (020438)

Used in qualitative procedures for the differentiation of Nocardiaspecies.

General description This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates several residues of the S6 ribosomal protein.

InformationNVP-BHG712 is a specificEphB4inhibitor withED50of 25 nM that discriminates between VEGFR and EphB4 inhibition: also shows activity against c-Raf, c-Src and c-Abl withIC50of 0.395 μM, 1.266 μM and 1.667 μM, respectively.In vitroNVP-BHG712